Cognitive decline and the PPAR-γ Pro12Ala genotype: variation by sex and ethnicity
Authors:
- 6 October 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 46 (1) , 96-100
Abstract
We investigated the association between the peroxisome proliferator-activated receptor (PPAR)-gamma Pro12Ala polymorphism and cognitive decline in older adults. participants from a population-based cohort of older Hispanic and non-Hispanic white adults (n = 492) were administered the Mini Mental State Examination (MMSE), a multi-domain cognitive screening tool, and the Behavioral Dyscontrol Scale (BDS), a measure of executive cognitive function, at baseline and at follow-up, an average of 22 months later. Multiple linear regression was used to investigate the association between the two cognitive test scores and the Pro12Ala polymorphism. at baseline, presence of the Ala12 allele was not significantly associated with MMSE score (P = 0.62) nor with BDS score (P = 0.85). Heterogeneity was present for cognitive decline as measured by the MMSE among ethnic, sex and Ala12 allele status (P = 0.04 for three-way interaction term). Stratification by the cross-classification of sex and ethnicity revealed significantly greater declines in MMSE score among male Hispanic carriers of the Ala12 allele compared to male Hispanic non-carriers (decline = 4.0 versus 1.6 points; P = 0.02). A significant difference in decline between Ala12 carriers and non-carriers was not present among the other sex/ethnic groups. carriers of the PPAR-γ Ala12 allele showed greater cognitive decline compared to non-carriers as detected by the MMSE but the risk varied across sex and ethnic groups. Male Ala12 carriers of Hispanic origin may be a high-risk group for cognitive decline.Keywords
Funding Information
- National Institutes of Health (DK-30747, CRC-RR00051)
- National Institute on Aging (AG-10940)
This publication has 23 references indexed in Scilit:
- Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2012
- The PPAR-gamma Pro12Ala polymorphism and risk of cognitive impairment in a longitudinal studyNeurobiology of Aging, 2010
- PPAR-γ Pro12Ala genotype and risk of cognitive decline in eldersNeurobiology of Aging, 2008
- Molecular basis of selective PPARγ modulation for the treatment of Type 2 diabetesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Candidate gene association study of insulin signaling genes and Alzheimer's disease: Evidence for SOS2, PCK1, and PPARγ as susceptibility lociAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007
- Methods and Prevalence of ADL Limitations in Hispanic and Non-Hispanic White Subjects in Rural ColoradoAnnals of Epidemiology, 1999
- Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense MutationBiochemical and Biophysical Research Communications, 1997
- The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, ColoradoAtherosclerosis, 1995
- Biological and psychological development of executive functionsBrain and Cognition, 1992
- “Mini-mental state”Journal of Psychiatric Research, 1975